Tekla Life Sciences Investors HQL

$ 13.86 0.43%

Tekla Life Sciences Investors EV/EBITDA Ratio 2011-2024 | HQL

Annual EV/EBITDA Ratio Tekla Life Sciences Investors

2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	2.49	1.65	1.37	4.35

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
4.35	1.37	2.47